Aprecia to invest $25M in Ohio plant; UN accuses Chinese drugmakers of aiding meth trade; Novartis touts efficiency gains from packaging tech;

> Aprecia Pharmaceuticals is to invest $25 million to turn a vacant building in Ohio into a production plant staffed by 150 people. More

> A United Nations official has accused corrupt elements of the Chinese pharmaceutical industry of supplying methamphetamine manufacturers with precursor chemicals. Article

> Novartis ($NVS) has explained how an investment in packaging technology allowed its plant in Cairo, India, to manufacture a wider range of products. Feature

> Nigerian regulators have destroyed counterfeit pharmaceuticals with an estimated value of $2.5 million. News

> Akorn Pharmaceuticals ($AKRX) has become the latest drugmaker to speak out against the use of midazolam for executions. The manufacturer will now only ship midazolam to a select group of wholesalers. Piece

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.